SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001127602-18-037524
Filing Date
2018-12-31
Accepted
2018-12-31 08:43:36
Documents
1
Period of Report
2016-08-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4a.html 4/A  
1 PRIMARY DOCUMENT form4a.xml 4/A 2525
  Complete submission text file 0001127602-18-037524.txt   3930
Mailing Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922
Business Address
MIDDLEKAUFF W BRADFORD (Reporting) CIK: 0001214501 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37568 | Film No.: 181258690

Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Issuer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations